Activ Surgical Announces FDA Clearance for ActivSight Intraoperative Imaging Module

Activ Surgical announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ActivSight Intraoperative Imaging Module for enhanced surgical visualization.

Metrex Surface Disinfectant Portfolio Secures EPA Approval

The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective against SARS-CoV-2, the novel coronavirus that causes COVID-19.

Olympus Supports Safety Actions Regarding Surgical Smoke

Olympus has announced its support of The Joint Commission’s recommended safety actions for managing the hazards of exposure to surgical smoke for health care staff in operating rooms.

Exofin Fusion Redesign Receives FDA Approval

Chemence Medical, a leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion skin closure system.

Fusion Robotics Completes First Spine Procedure

Fusion Robotics LLC, a spinal robotics and navigation company, announced the successful completion of the first spine procedure using the company’s technology platform. The procedure, completed by Dr. Kevin Foley at Baptist Memorial Hospital in Memphis Tennessee, was a single-level minimally invasive transforaminal lumbar interbody fusion (MI-TLIF), including the placement of pedicle screw fixation guided by the Fusion Robotics system.

“We’re thrilled to be the first hospital in the world to use this newly available technology. Our collaboration with Semmes Murphey, as a part of the Brain and Spine Network: Baptist + Semmes Murphey, provides the framework to propel us forward in neurosciences across our 22 hospital-system. The goal of our health system is to serve our patients by providing the right care at the right place, leading to the highest outcomes. With the surgical accuracy and price-point of this technology, it is easy to see that robotic technology will now become more available to both large medical centers, as well as, smaller regional hospitals; an opportunity that has not been available until now,” commented Kimberly Hallum-Stewart, system administrator for Neurosciences at Baptist.

John Lewis, executive director of Semmes Murphey Clinic said, “Our mission is to support the advancement of neuroscience and surgeon training to provide better outcomes for patients in our community and globally. It is the spirit of the clinic and the function of Semmes Murphey Clinic and our research foundation. This spinal navigation and robotics initiative with Baptist Memorial Health Care and Fusion Robotics illustrates us taking action to fulfill our mission by creating access to new technology that improves patient outcomes.”

Brad Clayton, CEO of Fusion Robotics, said, “We’re excited to team up with clinical partners to make a difference for patients; this is what it’s all about, and we’re just getting started.”

This first procedure was completed just weeks after the company received FDA clearance, illustrating its rapid progress towards a nation-wide launch in 2021. The company will be launching several new technologies in the near future, including a fluoroscopy-based robotic navigation system.



Submit a Comment

Your email address will not be published. Required fields are marked *